Intratumoural Administration of Coxsackievirus A21 for the Control of Malignant Melanoma
Coxsackievirus A21, a naturally occurring enterovirus, has shown that in vivo it can infect
and lyse melanoma. This study is to assess safety of a single intratumoural injection of
the virus into an accessible subcutaneous melanoma metastasis.
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Safety profile of treatment, characterisation of adverse events
Peter Hersey, MBBS, DPhil
Principal Investigator
Conjoint Professor, Newcastle Mater Misericordiae Hopital
Australia: Department of Health and Ageing Therapeutic Goods Administration
PSX-X-02
NCT00235482
August 2005
Name | Location |
---|